BiotechTube
NirvaMed

NirvaMed

San Jose, United States· Est.
nirvamedical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

NirvaMed is a private, pre-revenue medical device company founded in 2018, developing a novel catheter technology for cardiology applications. Its primary focus is on a heart cooling therapy for STEMI heart attacks, with a strategic expansion into the complex PCI market. The company is currently raising financing to advance product development, conduct clinical studies, and pursue 510(k) clearance within a four-year timeline, while operating with a unique US-Thailand research and development model.

Cardiology

Technology Platform

Proprietary catheter platform designed for intracardiac therapeutic cooling (hypothermia) and support during complex coronary interventions.

Opportunities

The large and growing global markets for STEMI treatment and complex PCI procedures represent significant commercial opportunities.
The company's dual-location strategy in Thailand and the US provides a substantial cost advantage in R&D, extending runway and improving capital efficiency compared to peers operating solely in high-cost regions.

Risk Factors

Key risks include technical/clinical failure of the novel cooling therapy, regulatory hurdles in obtaining 510(k) clearance, and the significant challenge of commercializing a new device in the crowded, competitive interventional cardiology market dominated by large incumbents.
The distributed operational model also introduces execution and coordination complexity.

Competitive Landscape

NirvaMed operates in the competitive interventional cardiology device space, competing against large, diversified players like Abbott, Medtronic, Boston Scientific, and Philips. While therapeutic hypothermia for cardiac applications is a niche, it faces competition from other organ-protection strategies and devices. For complex PCI, it would compete against specialized guide catheters, support catheters, and atherectomy devices from these same major firms.

More companies in Small Molecule Drugs →More companies in United States →